Phenicol antibacterials

US9340564B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9340564-B2
Application numberUS-201514731650-A
CountryUS
Kind codeB2
Filing dateJun 5, 2015
Priority dateMar 6, 2012
Publication dateMay 17, 2016
Grant dateMay 17, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention provides novel phenicol derivatives, their use for the treatment of infections in mammals, pharmaceutical composition containing these novel compounds, and methods for the preparation of these compounds.

First claim

Opening claim text (preview).

We claim: 1. A method for controlling or treating infections in livestock by administering to an animal in need of a therapeutically effective amount of a compound of Formula II, its enantiomers, diastereomers, or pharmaceutically acceptable salts thereof wherein W is —H or —PO(OH)2; and X and Y are each independently halo. 2. The method of claim 1 wherein X and Y are both fluoro. 3. The method of claim 1 wherein the livestock is cattle or swine. 4. The method of claim 3 wherein the livestock is cattle. 5. The method of claim 1 wherein the compound of Formula II is N-(1-(4-(6-(1- aminoethyl)pyridin-3-yl)phenyl)-3-fluoro-1-hydroxyprop an-2-yl)-2,2-difluoroacetamide, its enantiomers, diastereomers, or pharmaceutically acceptable salt thereof. 6. The method of claim 5 wherein the compound of Formula II is N-(( 1R,2S)-1-(4-(6-(RS)-1-aminoethyl)pyridin-3-yl)phenyl)-3-fluoro-1-hydroxypropan-2-yl)-2,2-difluoroacetamide or (1R,2S)-1-(4-(6-(RS)-1-aminoethyl)pyridin-3-yl)phenyl)-2-(2,2-difluoroacetamido )-3-fluoropropyl dihydrogen phosphate. 7. The method of claim 6 wherein the compound of Formula II is N-(( 1R,2S)-1-(4-(6-((S)-1-aminoethyl)pyridin-3-yl)phenyl)-3-fluoro-1-hydroxypropan-2-yl)-2,2-difluoroacetamide or (1R,2S)-1-(4-(6-((S)-1- aminoethyl)pyridin-3-yl)phenyl)-2- (2,2-difluoroacetamido)-3-fluoropropyl dihydrogen phosphate. 8. The method of claim 1 wherein the compound of Formula II is selected from: N-((1R,2S)-1-(4- (6- (1- aminoethyl)pyridin-3-yl)phenyl)-3-fluoro-1-hydroxypropan-2-yl)-2,2-dichloroacetamide; (1R,2S)-1-(4- (6- (1-aminoethyl)pyridin-3-yl)phenyl)-2-(2,2-dichloroacetamido)-3-fluoropropyl hydrogen phosphate sodium; (1R,2S)-1-(4-(6- (1- aminoethyl)pyridin-3-yl)phenyl)-2-(2,2-dichloroacetamido)-3-fluoropropyl dihydrogen phosphate; (1R,2S)-1-(4- (6-(1-aminoethyl)pyridin-3-yl)phenyl)-2-(2,2-difluoroacetamido)-3-fluoropropyl hydrogen phosphate sodium; and (1R,2S)-1-(4-(6-(1- aminoethyl)pyridin-3-yl)phenyl)-2-(2,2-difluoroacetamido)-3-fluoropropyl dihydrogen phosphate. 9. The compound N4(1R,2S)-1-(4-(6-(1-aminocyclopropyl)pyridin-3-yl) phenyl)-3-fluoro-1-hydroxypropan-2-yl)-2,2-difluoroacetamide, its enantiomers, diastereomers, or a pharmaceutically acceptable salt thereof.

Assignees

Inventors

Classifications

  • with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms · CPC title

  • having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom · CPC title

  • Ortho-condensed systems · CPC title

  • linked by a carbon chain containing only aliphatic carbon atoms · CPC title

  • directly linked by a ring-member-to-ring-member bond · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9340564B2 cover?
The present invention provides novel phenicol derivatives, their use for the treatment of infections in mammals, pharmaceutical composition containing these novel compounds, and methods for the preparation of these compounds.
Who is the assignee on this patent?
Zoetis Services Llc
What technology area does this patent fall under?
Primary CPC classification C07D401/06. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 17 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).